Latest News & Updates

Breaking News

  • 8 hours ago

  • Vaibhavi M.

NKGen Appoints Alzheimer’s Expert Bruce Miller To Advisory Board, Leads Scientific Development
Breaking News
Medicus Amends LifeArc Deal, Lowers Teverelix Royalties, Revises Licensing Terms For GnRH Antagonist Teverelix

Vaibhavi M.

Other trending news you may like to read

NKGen Appoints Alzheimer’s Expert Bruce Miller To Advisory Board, Leads Scientific Development

NKGen Biotech appoints Alzheimer’s and FTD expert Dr. Bruce Miller to strengthen its neurodegeneration cell therapy strategy.

Vaibhavi M.

Pharma Now

Medicus Amends LifeArc Deal, Lowers Teverelix Royalties, Revises Licensing Terms For GnRH Antagonist Teverelix

Medicus revises its LifeArc license for Teverelix, cutting royalties while preserving global development and commercial rights.

Vaibhavi M.

Pharma Now

BioStem Acquires BioTissue’s Surgical And Wound Care Business, Expands Wound Healing Portfolio

BioStem completes acquisition of BioTissue’s wound care business, adding Neox and Clarix to its regenerative medicine portfolio.

Vaibhavi M.

Pharma Now

Greenwich Lifesciences Advances GLSI-100 With FDA Approval Of Commercial Supply

Greenwich LifeSciences receives FDA clearance to use its first commercial GP2 lot in the Phase III GLSI-100 study.

Vaibhavi M.

Pharma Now